Combination chemotherapy of dacarbazine and fotemustine in disseminated malignant melanoma Marie-Françoise AvrilJean BonneterreJean-Pierre Bizzari Original Articles Pages: 81 - 84
Combination salvage chemotherapy using cisplatin and teniposide for patients with refractory germinal testicular tumors Toshihiko KotakeTsuneharu Miki Original Articles Pages: 85 - 88
Antitumor activity of a derivative of mitomycin, 7-N-[2-[[2-(γ-l-glutamylamino)ethyl]dithio]ethyl]mitomycin C (KW-2149), against murine and human tumors and a mitomycin C-resistant tumor in vitro and in vivo Takashi TsuruoYojiro SudoMakoto Morimoto Original Articles Pages: 89 - 93
Inflammatory carcinoma of the breast: results of a combined-modality approach — M. D. Anderson Cancer Center experience Eun H. KohAman U. BuzdarGabriel N. Hortobagyi Original Articles Pages: 94 - 100
Influence of aminoglutethimide on the metabolism of medroxyprogesterone acetate and megestrol acetate in postmenopausal patients with advanced breast cancer S. LundgrenP. E. LønningS. Kvinnsland Original Articles Pages: 101 - 105
The comparative disposition of [14C]-fotemustine in non-tumourous and tumourous mice R. M. J. IngsM. BreenD. B. Campbell Original Articles Pages: 106 - 110
Reaction kinetics of cisplatin and its monoaquated species with the (potential) renal protecting agents (di)mesna and thiosulfate O. R. LeeuwenkampW. J. F. van der VijghH. M. Pinedo Original Articles Pages: 111 - 114
A highly sensitive enzyme-linked immunosorbent assay for etoposide using β-d-galactosidase as a label Tetsuya SaitaKunio FujiwaraKatsumi Takata Original Articles Pages: 115 - 120
A new intraperitoneal tumor model in the rat J. D. NagelG. LosJ. G. McVie Original Articles Pages: 121 - 124
The effect of cimetidine on cyclophosphamide metabolism in rabbits Lowell B. AnthonyQi-cai LongKenneth R. Hande Original Articles Pages: 125 - 130
Phase I trial of 5-fluorouracil, leucovorin, and cisplatin in combination Peter J. O'DwyerMark J. CornfeldRobert L. Comis Original Articles Pages: 131 - 134
Intratumoural administration of cisplatin in slow-release devices Marc J. M. DeurlooSieb BohlkenAdrian C. Begg Original Articles Pages: 135 - 140
Cellular pharmacology of 1-β-d-arabinofuranosylcytosine in human myeloid, B-lymphoid and T-lymphoid leukemic cells Richard L. MomparlerNicole Onetto-PothierLouise F. Momparler Original Articles Pages: 141 - 146
Metabolism of epirubicin to glucuronides: relationship to the pharmacodynamics of the drug Jacques RobertMarc DavidCorinne Granger Original Articles Pages: 147 - 150
A simplified assay for measurement of cytosine arabinoside incorporation into DNA in Ara-C-sensitive and-resistant leukemic cells Louisa P. CollyDick J. RichelRoel Willemze Original Articles Pages: 151 - 156
Alteration of dacarbazine pharmacokinetics after interleukin-2 administration in melanoma patients Guy G. ChabotLawrence E. FlahertyLaurence H. Baker Original Articles Pages: 157 - 160
VIM-D salvage chemotherapy in Hodgkin's disease Julia K. PhillipsRuth L. SpearingJohn R. Nash Original Articles Pages: 161 - 163
7-Hydroxymethotrexate concentrations in serum and cerebrospinal fluid of children with acute lymphoblastic leukemia Joseph D. BorsiErling SagenPeter J. Moe Short Communication Pages: 164 - 167
Hydroxyurea-induced acute alveolitis in a Patient with chronic myeloid leukaemia Graham H. JacksonJonathon WallisStephen J. Proctor Short Communication Pages: 168 - 169